ELUCIDA ONCOLOGY Trademark
Trademark Overview
On Wednesday, February 26, 2020, a trademark application was filed for ELUCIDA ONCOLOGY with the United States Patent and Trademark Office. The USPTO has given the ELUCIDA ONCOLOGY trademark a serial number of 88811756. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Wednesday, February 24, 2021. This trademark is owned by Elucida Oncology, Inc.. The ELUCIDA ONCOLOGY trademark is filed in the Computer & Software Services & Scientific Services category with the following description:
Development of pharmaceutical preparations and medicines in the field of Oncology; Laboratory research services relating to pharmaceuticals, namely, preparations and diagnostic solutions in the field of Oncology; Pharmaceutical drug development services in the field of Oncology; Pharmaceutical products development in the field of Oncology; Pharmaceutical research and development in the field of Oncology
General Information
| Serial Number | 88811756 |
| Word Mark | ELUCIDA ONCOLOGY |
| Filing Date | Wednesday, February 26, 2020 |
| Status | 602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE |
| Status Date | Wednesday, February 24, 2021 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
| Disclaimer with Predetermined Text | "ONCOLOGY" |
| Description of Mark | The mark consists of the word "ELUCIDA" with an arrow underneath extending in to the letter "O" of the word "ONCOLOGY". |
| Goods and Services | Development of pharmaceutical preparations and medicines in the field of Oncology; Laboratory research services relating to pharmaceuticals, namely, preparations and diagnostic solutions in the field of Oncology; Pharmaceutical drug development services in the field of Oncology; Pharmaceutical products development in the field of Oncology; Pharmaceutical research and development in the field of Oncology |
| Translation of Words in Mark | The English translation of "ELUCIDA" in the mark is "ELUCIDATE". |
Classification Information
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, March 4, 2020 |
| Primary Code | 042 |
| First Use Anywhere Date | Monday, November 30, 2015 |
| First Use In Commerce Date | Tuesday, December 31, 2019 |
Trademark Owner History
| Party Name | Elucida Oncology, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Monmouth Junction, NJ 08852 |
Trademark Events
| Event Date | Event Description |
| Wednesday, February 24, 2021 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND |
| Wednesday, February 24, 2021 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| Thursday, August 13, 2020 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Thursday, August 13, 2020 | FINAL REFUSAL E-MAILED |
| Thursday, August 13, 2020 | FINAL REFUSAL WRITTEN |
| Thursday, July 23, 2020 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, July 22, 2020 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, July 22, 2020 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, May 18, 2020 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, May 18, 2020 | NON-FINAL ACTION E-MAILED |
| Monday, May 18, 2020 | NON-FINAL ACTION WRITTEN |
| Thursday, May 14, 2020 | ASSIGNED TO EXAMINER |
| Thursday, March 5, 2020 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Wednesday, March 4, 2020 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| Tuesday, March 3, 2020 | NEW APPLICATION ENTERED IN TRAM |
